Mosaic Family Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$349K Buy
5,753
+108
+2% +$6.3K 0.04% 216
2025
Q4
$304K Buy
5,645
+931
+20% +$44.8K 0.03% 191
2025
Q3
$208K Sell
4,714
-103
-2% -$4.81K 0.02% 222
2025
Q2
$223K Sell
4,817
-62
-1% -$3.04K 0.03% 212
2025
Q1
$298K Sell
4,879
-928
-16% -$54.1K 0.04% 173
2024
Q4
$328K Sell
5,807
-133
-2% -$7.43K 0.05% 158
2024
Q3
$307K Buy
5,940
+198
+3% +$9.29K 0.05% 164
2024
Q2
$238K Buy
5,742
+4
+0.1% +$179 0.04% 178
2024
Q1
$311K Sell
5,738
-215
-4% -$11K 0.05% 156
2023
Q4
$305K Sell
5,953
-91
-2% -$4.78K 0.05% 143
2023
Q3
$351K Sell
6,044
-68
-1% -$4.17K 0.07% 129
2023
Q2
$391K Sell
6,112
-10
-0.2% -$671 0.08% 118
2023
Q1
$424K Sell
6,122
-341
-5% -$24.1K 0.09% 111
2022
Q4
$465K Buy
+6,463
New +$487K 0.13% 107

Other funds holding BMY

Mosaic Family Wealth Partners's BMY Position: Q1 2026 in Review

Mosaic Family Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 1.9% in Q1 2026, buying an estimated $6.3K and bringing the position to 5,753 shares worth $349K. The position accounts for 0.04% of the portfolio, ranked #216.

Mosaic Family Wealth Partners first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $465K in Q4 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mosaic Family Wealth Partners held 5,753 shares of Bristol-Myers Squibb worth $349K as of Q1 2026.
  • Mosaic Family Wealth Partners bought 108 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.3K.
  • Bristol-Myers Squibb made up 0.04% of Mosaic Family Wealth Partners's portfolio in Q1 2026, its #216 holding.
  • Mosaic Family Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • Mosaic Family Wealth Partners's Bristol-Myers Squibb position peaked at $465K in Q4 2022.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mosaic Family Wealth Partners's 13F filing for Q1 2026, filed 30 Apr 2026.